Skip to content

Journal · Clinical Pharmacology · Updated 15 November 2026

Clinical Pharmacokinetics

Read Clinical Pharmacokinetics research on DeepDyve. No university library needed.

Clinical Pharmacokinetics, published by Springer Nature, has covered how drugs are absorbed, distributed, metabolized and eliminated in people since 1976. Its papers range from drug interaction studies and population pharmacokinetic models to reviews of dosing in patients with kidney or liver impairment. A DeepDyve subscription lets you read it in full, alongside millions of articles from other journals licensed from publishers including Springer Nature.

Then $59 a month or $499 a year. A credit card is required; cancel during the trial and you won’t be charged. You read articles online; PDFs are sold separately.

Personal plans aren’t for business use. Reading for work? See Enterprise.

Cover of Clinical Pharmacokinetics
Journal cover

Clinical Pharmacokinetics at a glance

Full title
Clinical Pharmacokinetics
Abbreviation (NLM)
Clin Pharmacokinet
Publisher
Springer Nature
Print ISSN
0312-5963
Online ISSN (eISSN)
1179-1926
First published
1976
Subjects
Pharmacology
Access model
Hybrid: subscription, with an open access option
On DeepDyve
Research articles; availability varies by article

Ways to access Clinical Pharmacokinetics

65% of the articles Clinical Pharmacokinetics published from January 1 to November 14, 2026 are open access and free to read. For the rest, look for the authors’ manuscript, check a library, or read them on DeepDyve.

  1. Open access articles. 65% of Clinical Pharmacokinetics articles published from January 1 to November 14, 2026 carry a Creative Commons license, per Crossref, and are free to read. They’re marked “Open access” below.
  2. The authors’ accepted manuscript. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication.
  3. Ask the authors. Authors can also share a free, read-only link to their published article through Springer Nature’s SharedIt, so it’s worth asking the authors directly.
  4. NIH-funded research. For papers accepted on or after July 1, 2025, the US National Institutes of Health requires the accepted manuscript in PubMed Central, free with no embargo from the official publication date.
  5. A library. Your university, hospital or public library may subscribe to Clinical Pharmacokinetics. Check its journal list and whether it offers remote access.
  6. DeepDyve. Read Clinical Pharmacokinetics articles online for $59 a month or $499 a year after a free first month. Articles marked LitStream below are in DeepDyve’s LitStream collection, which a subscription lets you read online. PDFs are sold separately, and availability varies by article.

Sources: Springer Nature self-archiving policy; NIH Public Access Policy; open access share from Crossref license data.

Recent Clinical Pharmacokinetics research worth reading

Published May to August 2026. Summaries describe what the authors report.

  1. Open accessDrug interactions · Prostate cancer

    Effect of Enzalutamide on Morphine Exposure in Patients with Prostate Cancer

    Comparing 12 men with prostate cancer taking morphine with enzalutamide and 12 taking morphine without it, the authors found similar morphine exposure (geometric mean ratio 1.01) but higher exposure to the metabolite morphine-6-glucuronide with enzalutamide (ratio 1.77).

    Op ‘t Hoog et al. · Clinical Pharmacokinetics, published online May 4, 2026 · DOI 10.1007/s40262-026-01640-6

  2. LitStreamTransplant pharmacology · Mycophenolic acid

    Impacts of Uremic Toxins on the Population Pharmacokinetics of Total Mycophenolic Acid and its Glucuronide Metabolite in Adult Kidney Transplant Recipients

    The authors built a population pharmacokinetic model of mycophenolic acid from 283 samples in 41 adult kidney transplant recipients and report that each uremic toxin had distinct interaction effects, with simulations identifying p-cresol sulfate as positively influencing total mycophenolic acid exposure.

    Al-Dajani et al. · Clinical Pharmacokinetics, published online May 1, 2026 · DOI 10.1007/s40262-026-01646-0

  3. LitStreamAntibiotic dosing · Vancomycin

    Precision Dosing of Vancomycin: A Systematic Review of Population Pharmacokinetics Models and Comparative Evaluation of Software Tools

    This systematic review covers 99 population pharmacokinetic models of vancomycin for adults and 13 precision dosing software tools, and the authors report only partial overlap between published models and those in the tools, limited transparency on model selection and a lack of model-level external validation.

    Clinical Pharmacokinetics, June 2026 · DOI 10.1007/s40262-026-01638-0

  4. Open accessOncology · Multiple myeloma

    Elranatamab Population Pharmacokinetics and Exposure–Response for Cytokine Release Syndrome in Patients with Relapsed or Refractory Multiple Myeloma

    Modeling 13,233 observations from 321 participants in four studies, the authors report approximately linear elranatamab pharmacokinetics with no clinically significant covariates, and identify early peak exposure and tumor burden as key predictors of cytokine release syndrome, primarily after the first step-up dose.

    Hibma et al. · Clinical Pharmacokinetics, published online June 13, 2026 · DOI 10.1007/s40262-026-01663-z

  5. LitStreamEpilepsy · Antiseizure medications

    Pharmacokinetics, Safety, and Dosing of Antiseizure Medications in Patients with Renal or Hepatic Impairment

    This narrative review covers pharmacokinetic data and FDA and EMA labeling for ten newer antiseizure medications in renal and hepatic impairment, and the authors report no uniform class effect and discrepancies between the two agencies’ labeling for all ten drugs.

    Wu et al. · Clinical Pharmacokinetics, published online August 21, 2026 · DOI 10.1007/s40262-026-01691-9

See every Clinical Pharmacokinetics article on DeepDyve

Questions about Clinical Pharmacokinetics

How can I read Clinical Pharmacokinetics articles without a subscription?

65% of Clinical Pharmacokinetics articles published from January 1 to November 14, 2026 are open access and free to read. For subscription articles, Springer Nature lets authors post their accepted manuscript on their own website as soon as it’s accepted, and in a repository such as PubMed Central 12 months after publication. Your library may also subscribe. DeepDyve lets you read Clinical Pharmacokinetics articles online for $59 a month or $499 a year after a free first month.

What is the abbreviation for Clinical Pharmacokinetics?

Clinical Pharmacokinetics’s NLM (PubMed) abbreviation is Clin Pharmacokinet.

What is the ISSN of Clinical Pharmacokinetics?

The print ISSN is 0312-5963 and the online ISSN is 1179-1926.

Is Clinical Pharmacokinetics open access?

Clinical Pharmacokinetics is a hybrid journal: most articles are published under the subscription model, and authors can choose to publish open access. From January 1 to November 14, 2026, 69 of 106 Clinical Pharmacokinetics articles (65%) carry a Creative Commons license, per Crossref.

Clinical Pharmacokinetics articles on DeepDyve are licensed from Springer Nature. Journal facts as of 15 November 2026.

Start reading Clinical Pharmacokinetics today

One month free, then less than $2 a day. Clinical Pharmacokinetics, plus millions of articles from thousands of journals.

Start free month

Like this: